Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitomycin C for Refractory Pharyngoesophageal Stenosis
NCT03540953Terminated
- Start
- Jan 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mitomycin c in Pharyngoesophageal Stenosis (PES). Primary endpoint: Dysphagia at 2 years. Started Jan 2015; status: terminated.
02
Drugs
mitomycin c
03
Conditions
Pharyngoesophageal Stenosis (PES)
Beyond the preview
Go deeper on NCT03540953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03540953.